芪黄益肾汤治疗72例慢肾衰患者的临床观察

《芪黄益肾汤治疗72例慢肾衰患者的临床观察》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、芭黄益肾汤治疗72例慢肾哀患者的临床观1.威海中医院肾病科山东威海264200；2.威海市立医院肾病科山东威海264200摘要：目的：观察芪黄益肾汤治疗慢肾袞脾肾气虚证患者的临床疗效。方法：72例慢性肾功能衰竭属脾肾气虚证患者随机分为治疗组和对照组，治疗组36例，对照组36例。在一般对症治疗基础上，治疗组给予芪黄益肾汤口服,对照组给予海昆肾喜胶囊U服，疗程为2个月，观察两组治疗前后中医证候积分、血肌酐变化。结果：治疗组总有效率为86.11%，对照组总有效率为69.45%,两组差异有统计学意义(P&l

2、t;0.05)；治疗组治疗前后血肌酐降低，两者治疗前后差异均有统计学意义(P<0.05),与对照组治疗前后变化比较也有统计学意义(P<0.05)o结论：芪黄益肾汤具有降低血肌酐、改善临床症状的作用，治疗慢性肾衰竭只有一定优势。关键词：芪黄益肾汤；慢性肾袞竭临床观察ObservetheClinicalEfficacyof"Qihuangyishendecoction"on72CasesofPatientswithChronicRenalFailureTongNingnigl，YuShuju

3、nl，Diao丫ajunl,ZhouShanshanl，HaoJunling2(1.Departmentofnephropathy,WeihaiHospitalofTraditionalChineseMedicine,ShandongProvince，Weihai,2642002.Departmentofnephropathy，WeihaiMunicipalHospital,ShandongProvince,Weihai,264200)ABSTRACTObjective：Toobservethecl

4、inicalefficacyofpatientswithchronicrenalfailurebeforeandaftertreatmentby“Qihuangyishendecoction’，.Method：Collected72casesofrchronicrenalfailuremettheadmissioncriteria，anddividedintotreatmentgroup(36cases)andcontrolgroup(36cases)randomly.Onthebasisofgen

5、eralsymptomatictreatment,treatmentgroupwastreatedwith“Qihuangyishendecoction”fortwomonths，whilethecontrolgroupwastreatedwith“HaikunshenxiCapsules’，.ObservedthechangeofsymptomscoresoftraditionalChinesemedicineandcreatininebeforeandaftertreatment.Results

6、：Thetotaleffectiverateinthetreatmentgroupwas86.11%，whilehecontrolgroupwas69.45%,sothedifferencewasstatisticallysignificant/P<0.05).Serumcreatininewasloweraftertreatmentinthetreatmentgroup,thedifferencewasstatisticallysignificant/P<0.05).Thechangeofs

7、erumcreatininebeforeandaftertreatmentincomparisonwiththecontrolgrouptherewasstatisticallysignificant(P<0.05).Conclusion：“Qihuangyishendecoction”haslowerserumcreatinineandimprovedtheclinicalefficacy.Thetreatmentofchronicrenalfailurehascertainadvantag

8、es.KeyWords：qihuangyishendecoction；chronicrenalfailure；clinicalcbservation慢性肾衰竭是临床的常见病、疑难病，自然人群的发病率为50/100万人-200/100万人，近年来每年平均以8%的速度增长，我国南京军区总医院的流行病学调査及临床研究显示，慢性肾衰竭的发病率约为568/100万，在人类死亡原因中占第5-9位［1］。因其患病率高、致残率高、医疗费用高，临床多提倡早期干预治疗，坚持病因治疗，避免